Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis
Zinzani, PL Chen, R Armand, P Johnson, NA Brice, P Radford, John A Ribrag, V Molin, D Vassilakopoulos, TP Tomita, A
Zinzani, PL
Chen, R
Armand, P
Johnson, NA
Brice, P
Radford, John A
Ribrag, V
Molin, D
Vassilakopoulos, TP
Tomita, A
Citations
Altmetric:
Abstract
Description
Date
2020
Publisher
Collections
Keywords
Type
Article
Citation
Zinzani PL, Chen R, Armand P, Johnson NA, Brice P, Radford J, et al. Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis. Leuk Lymphoma. 2020:1-5.